Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age13-45
SponsorEunice Dube

About this trial

Aim: The main goal of this observational study is to determine the prevalence of Human Papilloma Virus(HPV) infection, and Hepatitis B (Hep B) immunity amongst women of childbearing age 13 to 45 years) attending clinics at Mtshabezi Mission and Matobo clinic respectively; and assess behavioral risk factors of high school students at these catchment areas that can put them at risk for developing cancer of the cervix and liver.

Question: Can screening for cancer, and vaccination against Hep B and HPV, and cognitive behavior intervention help in preventing related cancers amongst these groups of participants.

Eligibility criteria

Qualifiers

None

Disqualifiers

males who are not enrolled in these participating High Schools.

children below the age of thirteen who are not enrolled in high schools and are not seeking prenatal, post-partum and family planning services at these selected health facilities during the project period.

Any eligible potential participant without a valid consent.

Any potential participant who is excluded by a doctor or midwife for a known contraindicating medical condition that can lead to potential harm to the participant or staff.

Trial design

Treatments tested in this trial

  • Gardasil 9 vaccine
  • Hepatitis B Virus Vaccine(HBV)
  • Cognitive Behavioral Therapy

Treatment groups

1,800 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Eunice Dube

Lead sponsor

National University of Science and Technology, Zimbabwe

Collaborator